These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2332939)

  • 21. Differential effects of chronic calcium channel blocker treatment on the inotropic response of diabetic rat myocardium to acute ethanol exposure.
    Brown RA; Sundareson AM; Lee MM; Savage AO
    Life Sci; 1996; 59(10):835-47. PubMed ID: 8761317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of nifedipine on severe experimental cataract in diabetic rats.
    Kametaka S; Kasahara T; Ueo M; Takenaka M; Saito M; Sakamoto K; Nakahara T; Ishii K
    J Pharmacol Sci; 2008 Apr; 106(4):651-8. PubMed ID: 18431041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of angiotensin II in retinal leukostasis in the diabetic rat.
    Chen P; Scicli GM; Guo M; Fenstermacher JD; Dahl D; Edwards PA; Scicli AG
    Exp Eye Res; 2006 Nov; 83(5):1041-51. PubMed ID: 16822509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effects of hydralazine and alpha- or beta-adrenergic blockers: the role of plasma renin activity.
    Gutkin M; Das B; Chin BK; Mezey K; Modlinger RS
    J Clin Pharmacol; 1977; 17(8-9):509-18. PubMed ID: 893737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of alpha 1-, alpha 2- and beta-adrenoceptor blockers on insulin secretion in the rat.
    Ahrén B; Lundquist I; Järhult J
    Acta Endocrinol (Copenh); 1984 Jan; 105(1):78-82. PubMed ID: 6141689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of PN 200-110, a new calcium antagonist, on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction elicited by selective alpha-adrenoceptor agonists and catecholamines in the pithed rat.
    Jie K; van Brummelen P; Timmermans PB; Thoolen MJ; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):72-86. PubMed ID: 2869738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation between blood pressure and plasma catecholamine concentration after administration of calcium antagonists to rats.
    Imai K; Higashidate S; Prados PR; Santa T; Adachi-Akahane S; Nagao T
    Biol Pharm Bull; 1994 Jul; 17(7):907-10. PubMed ID: 8000374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of different calcium antagonists and a calcium agonist on the metabolism of propranolol by isolated rat hepatocytes.
    Vercruysse I; Vermeulen AM; Belpaire FM; Massart DL; Dupont AG
    Fundam Clin Pharmacol; 1994; 8(4):373-8. PubMed ID: 7851843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pressor responses induced by Bay K 8644 involve both release of adrenal catecholamines and calcium channel activation.
    Moreland S; Ushay MP; Kimball SD; Powell JR; Moreland RS
    Br J Pharmacol; 1988 Apr; 93(4):994-1004. PubMed ID: 2455580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The differential effects of prazosin and hydralazine on sympathoadrenal activity in conscious rats.
    Keeton TK; Biediger AM
    Eur J Pharmacol; 1989 May; 164(3):479-86. PubMed ID: 2767118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium channel blocker drugs and diabetic control.
    Collins WC; Cullen MJ; Feely J
    Clin Pharmacol Ther; 1987 Oct; 42(4):420-3. PubMed ID: 3311549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibitory effects of calcium channel antagonist on the proliferation of vascular smooth muscle cells induced by adrenoceptor activators].
    Li Y; Wang R; Lin SX; Jia B; Song KM
    Sheng Li Xue Bao; 1995 Jun; 47(3):269-74. PubMed ID: 7570113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of calcium antagonists on hypertension and diabetes in new hypertensive diabetic models.
    Sato T; Nara Y; Note S; Yamori Y
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S192-4. PubMed ID: 2455131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The acute pressor response to cadmium in rats.
    Balaraman R; Gulati OD; Rathod SP; Bhatt JD
    Arch Int Pharmacodyn Ther; 1989; 301():254-66. PubMed ID: 2624515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of calcium channel antagonists on histamine and pentagastrin-stimulated gastric acid secretion in the rat.
    Bouclier M; Spedding M
    Agents Actions; 1985 Sep; 16(6):491-5. PubMed ID: 4072828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephroprotective effect of treatment with calcium channel blockers in spontaneously hypertensive rats.
    Sabbatini M; Vitaioli L; Baldoni E; Amenta F
    J Pharmacol Exp Ther; 2000 Sep; 294(3):948-54. PubMed ID: 10945845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium channel blockers inhibit the hyperglycemic effect of calcitonin.
    Butakova SS; Nozdrachev AD
    Bull Exp Biol Med; 2012 Mar; 152(5):553-9. PubMed ID: 22803131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: alterations in baroreflex sensitivity.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):376-82. PubMed ID: 6747841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors involved in the antihypertensive action of calcium antagonists.
    Garthoff B; Kazda S; Knorr A; Thomas G
    Hypertension; 1983; 5(4 Pt 2):II34-8. PubMed ID: 6345375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.